OGI trades at Wall Street's consensus target of —.
Last 12 months price action with 12-month analyst target path
The base valuation assumes OGI achieves its forward estimates and maintains a stable P/E multiple of 7.9x. This scenario reflects the blended consensus of 5 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 22, 2026, Organigram Global Inc. (OGI) has a Wall Street consensus price target of N/A, based on estimates from 5 covering analysts. The company has a market capitalization of $136M.
Analyst price targets range from a low of N/A to a high of N/A.
The current analyst consensus rating is Buy, with 2 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 1 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, OGI trades at a trailing P/E of -9.8x and forward P/E of 7.9x. Analysts expect EPS to grow +164.1% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
CGCCanopy Growth Corporation | $372M | $0.97 | $14.47 | +1396.1% | Hold | — | 26 |
TLRYTilray Brands, Inc. | $551M | $4.73 | $10.00 | +111.4% | Hold | — | 20 |
ACBAurora Cannabis Inc. | $181M | $2.93 | $5.92 | +102.0% | Hold | — | 14 |
CRONCronos Group Inc. | $1.0B | $2.71 | $2.30 | -15.1% | Hold | 31.0x | 15 |
SNDLSNDL Inc. | $368M | $1.42 | $3.95 | +178.2% | Hold | — | 6 |
SMGThe Scotts Miracle-Gro Company | $3.8B | $64.69 | $72.25 | +11.7% | Buy | 14.9x | 17 |
IIPRInnovative Industrial Properties, Inc. | $1.7B | $59.60 | $84.67 | +42.1% | Hold | 13.9x | 11 |
LWAYLifeway Foods, Inc. | $389M | $25.43 | $35.00 | +37.6% | Buy | 22.9x | 7 |
VFFVillage Farms International, Inc. | $218M | $1.91 | $6.15 | +222.0% | Buy | 12.1x | 9 |
GRWGGrowGeneration Corp. | $96M | $1.59 | $4.17 | +162.3% | Buy | — | 12 |
Quick answers to the most common questions about buying OGI stock.
The consensus price target for OGI is $N/A, close to the current price of $0.9647 (N/A% implied move). Based on 5 analyst estimates, the stock appears fairly valued near current levels.
OGI has a consensus rating of "Buy" based on 5 Wall Street analysts. The rating breakdown is mixed, with 2 Hold ratings making up the largest segment. The consensus 12-month price target of $N/A implies N/A% upside from current levels.
With a forward P/E of 7.9334x, OGI trades at a relatively low valuation. The consensus target of $N/A implies N/A% appreciation, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $N/A for OGI, while the most conservative target is $N/A. The consensus of $N/A represents the median expectation. These targets typically reflect 12-month expectations.
OGI is moderately covered, with 5 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 2 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month OGI stock forecast based on 5 Wall Street analysts shows a consensus price target of $N/A, with estimates ranging from $N/A (bear case) to $N/A (bull case). The median consensus rating is "Buy".
OGI trades at a forward P/E ratio of 7.9x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
OGI appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $N/A target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
OGI analyst price targets range from $N/A to $N/A, a NaN% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $N/A consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.